Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date
tags : Fda save search
Altamira Therapeutics Receives FDA 510(k) Clearance for Bentrio to Treat Allergic Rhinitis
Published: 2022-06-27 (Crawled : 13:00) - biospace.com/
CYTO | News | $0.5792 13.35% -0.2% |
|
Manufacturing
|
| O: 22.36%
H: 0.0%
C: -13.62%
fda clearance for therapeutics
Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of Major Depressive Disorder
Published: 2022-06-27 (Crawled : 13:00) - biospace.com/
CYBN | News | $0.615 4.7% 0.81% |
|
n/a
|
| O: 0.44%
H: 8.47%
C: 4.24%
cyb003 treatment fda clearance for trial potential
ADMA BioCenters Receives FDA Approval for its Sixth Plasma Collection Center, Located in Myrtle Beach, SC
Published: 2022-06-27 (Crawled : 12:00) - admabiologics.com
ADMA | News | $2.16 11.34% 1.03% |
|
Health Technology
|
| O: -0.74%
H: 6.93%
C: 6.93%
fda for approval
Nuvation Bio Announces FDA Partial Clinical Hold for Phase 1 Study of NUV-422 in Solid Tumors
Published: 2022-06-27 (Crawled : 12:00) - biospace.com/
NUVB | News | $3.64 -13.13% 0.0% |
|
|
| O: -2.25%
H: 0.12%
C: -11.97%
nuv-422 fda for
Todays' Top-5
Acutus Medical Announces FDA Clearance, Commercial Launch of AcQCross™ Line Extension Compatible with Watchman™ Delivery SystemInnovative Transseptal Access System Is First and Only to Feature Integrated Dilator and Needle to Reduce Exchanges
Published: 2022-06-27 (Crawled : 11:00) - biospace.com/
AFIB | News A | $1.015 88.52% 14.82% |
|
Health Technology
|
| O: 85.93%
H: 0.0%
C: 0.0%
fda system extension commercial
Astellas Announces FDA Update on the FORTIS Clinical Trial of AT845 in Adults with Late-Onset Pompe Disease
Published: 2022-06-27 (Crawled : 08:00) - biospace.com/
ALPMY | News | $16.205 |
|
Manufacturing
|
| O: -1.2%
H: 0.0%
C: -0.37%
at845 fda disease trial update
Astellas Announces FDA Update on the FORTIS Clinical Trial of AT845 in Adults with Late-Onset Pompe Disease
Published: 2022-06-26 (Crawled : 00:00) - prnewswire.com
ALPMY | News | $16.205 |
|
Manufacturing
|
| O: -1.2%
H: 0.0%
C: -0.37%
at845 fda disease trial update
Cytokinetics Announces Date for FDA Advisory Committee Meeting to Review New Drug Application for Omecamtiv Mecarbil
Published: 2022-06-24 (Crawled : 12:00) - globenewswire.com
CYTK | $48.93 3.56% 0.0% |
|
Health Technology
|
| O: 9.47%
H: 0.25%
C: -1.52%
fda drug for meeting application review
Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate
Published: 2022-06-24 (Crawled : 11:00) - globenewswire.com
EBS | $32.65 -0.34% 0.0% |
|
Health Technology
|
| O: 6.55%
H: 0.91%
C: -0.27%
av7909 fda candidate for vaccine application license
Astellas Submits Fezolinetant New Drug Application to U.S. FDA
Published: 2022-06-23 (Crawled : 00:00) - prnewswire.com
ALPMF | News | $15.83 |
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: -0.5%
ALPMY | News | $16.205 |
|
Manufacturing
|
| O: 4.33%
H: 0.0%
C: -2.44%
fda drug application
CNS Pharmaceuticals Receives Approval from U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
Published: 2022-06-23 (Crawled : 13:20) - biospace.com/
CNSP | $0.2611 -1.4% 4.61% |
|
Health Technology
|
| O: 32.07%
H: 1.89%
C: -24.85%
RETA | $32.88 5.79% 4.99% |
|
Health Technology
|
| O: -0.09%
H: 3.99%
C: 3.0%
treatment fda ongoing for trial approval berubicin
Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-2059, an Investigational Small Molecule-Based Radiopharmaceutical Targeting Solid Tumors Expressing NTSR1
Published: 2022-06-23 (Crawled : 12:00) - prnewswire.com
FUSN A | $2.75 11.64% |
|
Health Technology
|
| O: 4.31%
H: 5.01%
C: -19.47%
fpi-2059 fda clearance for
Novartis Tafinlar + Mekinist receives FDA approval for first tumor-agnostic indication for BRAF V600E solid tumors
Published: 2022-06-22 (Crawled : 00:00) - globenewswire.com
NVS | News | $85.28 0.53% 0.02% |
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
fda for novartis approval tafinlar
Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant
Published: 2022-06-22 (Crawled : 21:00) - globenewswire.com
RDUS | News | $10.205 0.94% -0.4% |
|
Health Technology
|
| O: 12.68%
H: 8.17%
C: 7.97%
fda elacestrant drug for health application group
U.S. FDA Approves Merck’s VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Infants and Children
Published: 2022-06-22 (Crawled : 17:00) - biospace.com/
MRK | News | $94.41 1.37% 0.27% |
|
Health Technology
|
| O: 3.24%
H: 2.61%
C: 1.27%
fda disease for children
VBI Vaccines Receives U.S. FDA Orphan Drug Designation for VBI-1901 for the Treatment of Glioblastoma
Published: 2022-06-22 (Crawled : 12:20) - biospace.com/
VBIV | $0.8496 -7.36% 6.74% |
|
Health Technology
|
| O: 8.21%
H: 26.11%
C: 16.65%
vbi-1901 treatment fda designation drug for
ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Clorazepate Dipotassium Tablets USP
Published: 2022-06-22 (Crawled : 12:00) - biospace.com/
ANIP | $30.095 4.1% 0.0% |
|
Health Technology
|
| O: 6.12%
H: 1.73%
C: -0.88%
fda approval
Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001
Published: 2022-06-21 (Crawled : 16:00) - biospace.com/
ACER | News A | $1.42 16.39% 0.0% |
|
Health Technology
|
| O: -10.23%
H: 0.0%
C: 0.0%
acer-001 fda drug for application therapeutics review update
Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Published: 2022-06-21 (Crawled : 16:00) - biospace.com/
RGLS | $0.225 -6.48% 5.99% |
|
Health Technology
|
| O: 3.45%
H: 0.0%
C: 0.0%
rgls8429 treatment fda designation drug disease for kidney therapeutics
AbbVie Submits Supplemental New Drug Application to U.S. FDA for Atogepant (QULIPTA™) to Support Label Expansion for the Preventive Treatment of Migraine
Published: 2022-06-21 (Crawled : 14:00) - biospace.com/
ABBV | News | $153.14 0.53% 0.04% |
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
treatment fda expansion drug label for application migraine
Your saved searches
Save your searches and get alerts when important news are released.
Mentioned Today
ABBV | News | $153.14 0.53% 0.04% |
|
Health Technology
APPN | News 4 | $54.46 -1.05% 0.38% |
|
Technology Services
APPS | News | $17.62 1.62% 5.48% |
|
Technology Services
APYX | News | $6.04 1.51% 0.0% |
|
Health Technology
BNPQF | News | $50.78 |
|
Finance
BNPQY | News | $25.46 |
|
Finance and Insurance
BNPZY | News | $ 0% |
|
Finance and Insurance
CNXC | News | $147.67 1.63% -0.04% |
|
Information
CNXCV | News | $2.27 0% |
|
Commercial Services
DMYD | News | $16.21 0% |
|
Finance
DMYT | News | $22.76 0% |
|
Finance
DRE | News | $56.17 -2.23% 0.0% |
|
Finance
EPZM | News | $1.47 54.09% 7.97% |
|
Health Technology
ET | News | $10.14 0.4% 0.59% |
|
Industrial Services
FBNC | News | $35.7 2.32% 0.0% |
|
Finance
FBP | News | $13.52 0.67% 0.0% |
|
Finance
FTRP | News | $0.81 1.25% 0.0% |
|
Health Care and Social Assistan...
GRRB | News | $30.6 |
|
Finance and Insurance
HR | News | $27.23 1.38% 0.0% |
|
Finance
HTA | News | $27.7 -0.22% 0.0% |
|
Finance
IE | News 0 d new | $ 0% |
|
n/a
IONQ | News | $4.83 -5.48% 2.07% |
|
Professional, Scientific, and T...
LLY | News 4 | $327.27 0.51% 0.04% |
|
Health Technology
LMPX | News | $4.62 0.43% 0.0% |
|
Technology Services
NFLX | News | $189.14 -0.9% 0.52% |
|
Consumer Services
OBCI | News | $12.86 0.0% |
|
Consumer Non-Durables
OMC | News | $64.75 0.23% 0.0% |
|
Commercial Services
ONEW | News | $35.25 3.68% 0.0% |
|
Retail Trade
OSCR | News | $4.55 2.94% 0.0% |
|
PACB | News | $5.3 -5.53% -1.78% |
|
Health Technology
PEGA | News | $51.68 -1.97% 0.0% |
|
Technology Services
PFHC | News | $19.75 6.35% -4.95% |
|
PLD | News | $120.21 -1.94% 0.54% |
|
Finance
PSORF | News | $9.55 0% |
|
Consumer Services
RDUS | News | $10.205 0.94% -0.4% |
|
Health Technology
SNY | News | $52.62 -1.5% -0.41% |
|
Health Technology
SNYNF | News | $104.5 |
|
Health Technology
SPRO | News | $0.931 -0.96% 3.19% |
|
Health Technology
SREV | News | $1.45 -2.76% |
|
Technology Services
TGTX | News | $4.34 -1.36% -2.05% |
|
Health Technology
TUP | News 4 | $7.16 1.42% 0.0% |
|
Producer Manufacturing
USAK | News | $30.85 -0.48% -0.39% |
|
Transportation
USWS | News | $0.995 4.08% -0.63% |
|
Finance
VRCA | News | $2.195 4.03% 10.43% |
|
Health Technology
WWE | News | $61.0 0.63% 0.0% |
|
Consumer Services
XRAY | News | $36.74 -0.05% 0.0% |
|
Health Technology
ZEN | News | $74.65 0.65% -0.07% |
|
Technology Services